Prophaze Technologies Revenue and Competitors

Cochin,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Prophaze Technologies's estimated annual revenue is currently $4.4M per year.(i)
  • Prophaze Technologies's estimated revenue per employee is $116,000

Employee Data

  • Prophaze Technologies has 38 Employees.(i)
  • Prophaze Technologies grew their employee count by 12% last year.

Prophaze Technologies's People

NameTitleEmail/Phone
1
VP SalesReveal Email/Phone
2
Systems Engineer - SecurityReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$57.6M31824%N/AN/A
#2
$44.6M28623%$25.4MN/A
#3
$5.1M44-6%N/AN/A
#4
$35.1M225-3%$46.9MN/A
#5
$14.5M1005%N/AN/A
#6
$1.3M15-6%N/AN/A
#7
$1.5M170%N/AN/A
#8
$2.9M29-12%N/AN/A
#9
$125.2M6916%N/AN/A
#10
$95.9M529-1%N/AN/A
Add Company

What Is Prophaze Technologies?

Prophaze WAF secures your Kubernetes deployment from OWASP Top 10 Vulnerabilities by running inside your Ingress Controller. Prophaze Offers Cloud WAF as a Service for mid-market segments.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$4.4M

Revenue (est)

12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Prophaze Technologies News

2022-04-19 - ProPhase Labs to Present at the Planet MicroCap Showcase ...

Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, ... subsidiary of ProPhase, focuses on genomics testing technologies,...

2022-04-13 - Zacks.com featured highlights ProPhase Labs, Hudson Technologies and YPF Sociedad Anonima

Chicago, IL – April 19, 2022 – Stocks in this week's article are ProPhase Labs PRPH, Hudson Technologies HDSN and YPF Sociedad Anonima YPF.

2022-03-22 - ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q4 2021 Results - Earnings Call Transcript

It's the collection of patient data and the reporting of results. I am proud to say that we have one of the best, most automated technology...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M420%N/A
#2
$5M43N/AN/A
#3
$3.5M442%N/A
#4
$4.3M4410%N/A
#5
$2.9M5035%N/A